These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8377337)

  • 1. [A trial of the use of a new thrombolytic preparation--recombinant tissue-type plasminogen activator--in myocardial infarct patients].
    Plotnikov AN; Staroverov II; Tagieva IA; Dorogun BN; Pomerantsev EV; Dobrovol'skiĭ AB; Ruda MIa
    Kardiologiia; 1993; 33(3):32-6. PubMed ID: 8377337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage].
    Staroverov II; Dundua DP; Plotnikov AN; Pomerantsev EV; Bliumental' AA; Puchkov AT; Ovasapian IuA; Serov VP; Ruda MIa
    Kardiologiia; 1993; 33(3):28-32. PubMed ID: 8377336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction.
    Gao R; Chen J; Kou W; Yao K; Xu Y; Lu Z; Yu Q; Tao P; Ma J; Zhu J
    Chin Med Sci J; 1991 Sep; 6(3):132-5. PubMed ID: 1793874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients].
    Jorge Sdo C
    Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of recombinant tissue plasminogen activator infusion in acute myocardial infarction.
    Wang SP; Liu CP; Charng MJ; Chou CY; Tsai JH; Pan JP; Shyong WC; Chan WL; Kong CW; Chang MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Apr; 43(4):223-8. PubMed ID: 2509051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIMI grade flow, mortality, and the GUSTO-III trial.
    Stringer KA
    Pharmacotherapy; 1998; 18(4):699-705. PubMed ID: 9692644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group.
    Karlsson JE; Berglund U; Björkholm A; Ohlsson J; Swahn E; Wallentin L
    Am Heart J; 1992 Dec; 124(6):1419-26. PubMed ID: 1462894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
    Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
    Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaphylactoid reaction during administration of tissue plasminogen activator (t-PA)].
    Cannas S; De Leo A; Marzari A
    G Ital Cardiol; 1997 Mar; 27(3):278-80. PubMed ID: 9244730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous hemarthrosis following thrombolytic therapy for acute myocardial infarction.
    Birnbaum Y; Stahl B; Rechavia E
    Int J Cardiol; 1993 Jul; 40(3):289-90. PubMed ID: 8225665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombolysis in acute myocardial infarction. Streptokinase or r-TPA?].
    Silva LA; Ribeiro E; Carneiro RC; Kaissar S; Reis Filho A; Torossian SP; Tavares JR; Buffolo E; Amino JG; Duprat Filho R
    Arq Bras Cardiol; 1990 Jul; 55(1):13-7. PubMed ID: 2127353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antecedent angina pectoris predicts worse outcome after myocardial infarction in patients receiving thrombolytic therapy: experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI; White HD; Modan M; Van de Werf F
    J Am Coll Cardiol; 1992 Jul; 20(1):36-41. PubMed ID: 1607536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between admission mean platelet volume and coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yaşar AS; Bilen E; Yüksel IO; Arslantaş U; Karakaş F; Kirbaş O; Bilge M
    Turk Kardiyol Dern Ars; 2010 Mar; 38(2):85-9. PubMed ID: 20473008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat infusion of recombinant tissue-type plasminogen activator in patients with acute myocardial infarction and early recurrent myocardial ischemia.
    Barbash GI; Hod H; Roth A; Faibel HE; Mandel Y; Miller HI; Rath S; Zahav YH; Rabinowitz B; Seligsohn U
    J Am Coll Cardiol; 1990 Oct; 16(4):779-83. PubMed ID: 2120309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.